Physician profile
James R Field
NPI 1740229137
$4,398.87
in general payments reported to CMS, 2019-2025
8 companies · $1,741 in 2025
The $1,741 reported for 2025 was more than what 89% of Diagnostic Radiology providers received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $53.98 · 2020: $153 · 2022: $79.09 · 2023: $713 · 2024: $1,659 · 2025: $1,741.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $3,538 · Food and Beverage: $575.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $3,537.78 |
| Food and Beverage | $575.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $3,551.25 | 2022-2025 | Venacure 1470 Pro |
| Inari Medical, INC. | $471.04 | 2020-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Stryker Corporation | $141.29 | 2025 | Flowtriever, Inthrill Thrombectomy Catheter |
| Varian Medical Systems, INC. | $96.59 | 2020 | |
| Bard Peripheral Vascular, INC. | $53.98 | 2019 | |
| Pfizer INC. | $41.27 | 2022-2023 | |
| Boston Scientific Corporation | $21.76 | 2023 | Therasphere Y90 Glass Microspheres 10 Gbq |
| Covidien LP | $21.69 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Field listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.